Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Bilateral sensorineural hearing impairment.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 1 | Bilateral sensorineural hearing impairment |
MAP1B encodes microtubule associated protein 1B (2,468 aa). Facilitates tyrosination of alpha-tubulin in neuronal microtubules. Highest expression in Brain Cerebellar Hemisphere (262.6 TPM) and Brain Cerebellum (227.2 TPM).
Hearing loss, autosomal dominant 83 is associated with mutations in the MAP1B gene on chromosome 5.
MAP1B is classified as a druggable target with score 0.0.
Genetic testing for MAP1B is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature.
No clinical trials have been registered for hearing loss, autosomal dominant 83.
2 publications have been identified in PubMed for hearing loss, autosomal dominant 83. Research spans Case Report / Case Series (50%) and Basic Science / Preclinical (50%).
Han W (2025). [PMID: 39849854](https://pubmed.ncbi.nlm.nih.gov/39849854/). *Hum Mol Genet*. [Case Report / Case Series]
Yu S (2024). [PMID: 39720982](https://pubmed.ncbi.nlm.nih.gov/39720982/). *Mol Genet Genomics*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC
Online Mendelian Inheritance in Man